Medical XpressResearchers test stem cell-based retinal implant for common cause of vision lossMedical XpressThe treatment, which consists of a layer of human embryonic stem cell-derived retinal pigment epithelium cells on an ultrathin supportive struct… Continue reading
UANews (press release) |
Immunotherapy: Cancer’s New Frontier
UANews (press release) Many cancer researchers are optimistic about immunotherapy, a treatment that harnesses the power of the immune system, teaching it to recognize — and destroy — cancer cells. “An educated immune cell, like a guided missile, can specifically recognize … Staying Alive: Immunotherapy Offers Hope to Some Cancer PatientsCALIFORNIA |
Muscular Dystrophy News |
New Gene Editing Strategy Leads to Much Longer Protein Production
Muscular Dystrophy News American researchers have developed a new way of delivering a gene editing therapy that significantly increases the time a repaired gene can generate the protein that’s missing in a disease. This means that a gene therapy does not have to be repeated … |
|
Benefit of GenSight’s gene therapy not so clear
BioPharma Dive GenSight Biologics SA on April 3 announced topline results from the Phase 3 REVERSE trial that evaluated a single, intravitreal injection of its gene therapy candidate GS010 in 37 subjects with an inherited, degenerative eye disease who began losing … |
Xconomy |
Lilly’s next diabetes play would have patients swallow engineered stem cells
BioPharma Dive Eli Lilly & Co. and a freshly formed Massachusetts biotech are working to create a new kind of diabetes treatment: one that would have patients downing a capsule filled with insulin-producing cells. Sigilon Therapeutics Inc., which launched in mid-2017 … Lilly Licenses Sigilon’s Cell Encapsulation Tech for Diabetes TherapyXconomy Eli Lilly jumps into a $473M hunt with Sigilon for the Holy Grail in diabetes cell therapiesEndpoints News Lilly and Sigilon Therapeutics Announce Strategic Collaboration to Develop Encapsulated Cell Therapies for the …Markets Insider The Pharma Letter –FierceBiotech all 79 news articles » |
Stanford Medical Center Report |
Scientists combine CRISPR, DNA barcoding to track cancer growth
Stanford Medical Center Report The combination of CRISPR-Cas9 and DNA barcoding could allow scientists to replicate in the lab the kind of genetic diversity observed in cancer patients. “It gets around this fear of the complexity of cancer,” Winters said. “We’ve known for decades … |